Release Date: 12/10/21 16:19 Summary: Proposal to Delist from ASX Price Sensitive: Yes Download Document 1.46MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%